Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade B 26.43 -1.93% -0.52
OPTN closed down 1.93 percent on Thursday, July 19, 2018, on 70 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical OPTN trend table...

Date Alert Name Type % Chg
Jul 19 New Downtrend Bearish 0.00%
Jul 19 Stochastic Reached Oversold Weakness 0.00%
Jul 19 Oversold Stochastic Weakness 0.00%
Jul 17 New Uptrend Bullish -0.71%
Jul 17 Down 3 Days in a Row Weakness -0.71%
Jul 17 Down 4 Days in a Row Weakness -0.71%
Jul 16 New Downtrend Bearish -1.75%
Jul 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.75%
Jul 16 Doji - Bullish? Reversal -1.75%
Jul 16 Down 3 Days in a Row Weakness -1.75%

Older signals for OPTN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Is OPTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.0
52 Week Low 15.01
Average Volume 291,562
200-Day Moving Average 0.0
50-Day Moving Average 25.1032
20-Day Moving Average 27.539
10-Day Moving Average 27.865
Average True Range 1.3268
ADX 29.1
+DI 17.2611
-DI 17.9355
Chandelier Exit (Long, 3 ATRs ) 26.0196
Chandelier Exit (Short, 3 ATRs ) 27.5504
Upper Bollinger Band 29.9023
Lower Bollinger Band 25.1757
Percent B (%b) 0.27
BandWidth 17.163296
MACD Line 0.6801
MACD Signal Line 1.0615
MACD Histogram -0.3814
Fundamentals Value
Market Cap 998.03 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -1.35
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.38
Resistance 3 (R3) 28.45 27.86 28.06
Resistance 2 (R2) 27.86 27.37 27.83 27.95
Resistance 1 (R1) 27.15 27.06 26.86 27.08 27.84
Pivot Point 26.56 26.56 26.42 26.53 26.56
Support 1 (S1) 25.85 26.07 25.56 25.78 25.02
Support 2 (S2) 25.26 25.76 25.23 24.91
Support 3 (S3) 24.55 25.26 24.81
Support 4 (S4) 24.48